Genetic Testing for All Breast Cancer Patients (GET FACTS)

  • STATUS
    Recruiting
  • participants needed
    450
  • sponsor
    Dana-Farber Cancer Institute
Updated on 19 February 2024
cancer
breast cancer
breast carcinoma
genetic counseling
cancer diagnosis
genetic testing

Summary

This study is designed to determine the impact of a novel genetic counseling method on surgical decisions in individuals with newly diagnosed breast cancer

This research study involves an expedited and surgery-specific form of genetic counseling.

The names of the study methods involved in this trial are/is:

  • Quantitative genetic counseling (discussion is guided by tables and graphs)
  • Standard genetic counseling

Description

  • The research study procedures include screening for eligibility and study interventions including evaluations and follow up visits
    • After receiving genetic testing, participants will be placed into one of two counseling methodology groups:
    • Standard genetic counseling: Standard of care discussion
    • Quantitative genetic counseling: Discussion is guided by tables and graphs.
    • Participants will be on the research study for up to six months, with an optional extension to two years.
    • It is expected that about 450 people will participate.
    • This research study is a Feasibility Study, which is the first-time investigators are examining this form of genetic counseling.
    • This is a randomized study. Randomization means being put into a group by chance. It is like flipping a coin. Neither the participant nor the Investigator will choose the group the participant is assigned to.

Details
Condition Genetic Testing, Breast Cancer, Breast Cancer, Invasive Breast Cancer, in Situ Breast Cancer
Age 18-100 years
Treatment Standard Genetic Counseling, Quantitative Genetic Counseling
Clinical Study IdentifierNCT04245176
SponsorDana-Farber Cancer Institute
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Patients with a new breast cancer diagnosis (invasive or in-situ) considering genetic testing
Patients with good understanding of written and spoken English
Patients with apparent cognitive capacity to make surgical decisions for themselves
Patients who are medically cleared for surgery
Patients must be at least age 18

Exclusion Criteria

Previous breast cancer diagnosis (invasive or DCIS)
Metastatic breast cancer
Patients who have received prior broad-based panel testing (prior BRCA1/2 testing with negative results allowed)
Bilateral breast cancer
Known medical or surgical contraindication to contralateral mastectomy
Hematologic malignancy necessitating skin biopsy/fibroblast culture for germline genetic testing malignancy other than cervical cis or basal or squamous cell skin cancers
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.